Scientists scan brains of people with autism and fragile x to spot key differences
NCT ID NCT02719951
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study used special PET and MRI scans to look at brain activity in 27 men with autism, Fragile X syndrome, or no condition. The goal was to measure a brain chemical called glutamate, which helps nerve cells communicate. Researchers hope this will reveal how brain signaling differs in these conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [18F]FPEB (a radioactive tracer for PET scans)
- What this could lead to
- If successful, this could help researchers better understand brain chemistry differences in autism and Fragile X syndrome.
- What could go wrong
- This is a small, early-phase imaging study, not a treatment trial. It may not lead to direct benefits for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Tours
Tours, 37044, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gentle massage and calming sounds: a new bedtime ritual for autistic kids?
- Can a camera catch autism signs in preemie toddlers?
- Light-Up training pods may sharpen reflexes in autistic teen athletes
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could online coaching for parents boost autistic Children's social skills?